ALM vs ORLA

ALM's deterministic health scores signal severe financial distress: the Piotroski F-Score of 1/9 indicates extreme weakness in operational and financial health, while the absence of an Altman Z-Score raises unquantified bankruptcy risk. Despite strong revenue growth (28% YoY) and a bullish analyst consensus (strong_buy), the company reports a negative profit margin (-216.27%), negative ROE (-57.31%), and negative earnings, rendering valuation metrics like Forward P/E (87.79) and Price/Book (31.95) meaningless. The stock trades at a massive premium to its fundamentals, with no intrinsic value or Graham Number available, suggesting speculative pricing. Insider activity is neutral, and the recent 20.2% one-week decline underscores high volatility and potential overvaluation.

ORLA presents a classic high-growth profile with a stable Piotroski F-Score of 4/9, though it currently trades at a significant premium to its Graham Number ($3.61) and Intrinsic Value ($8.85). While the company exhibits explosive revenue growth (308% YoY) and strong operating margins, the technical trend is severely bearish (0/100) with a recent 18.8% monthly decline. The stark contrast between the trailing P/E (43.67) and Forward P/E (7.39) suggests a massive expected earnings surge, but current valuation remains stretched relative to defensive benchmarks.